Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/1996
03/14/1996WO1996007423A1 Immunomodulating medicinal agent
03/14/1996WO1996007414A1 Ointment
03/14/1996WO1996007401A1 Laminated tablet with pointed core
03/14/1996WO1996007400A1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
03/14/1996WO1996007399A1 Sustained release preparation containing metal salt of a peptide
03/14/1996WO1996007398A2 Sustained release of peptides from pharmaceutical compositions
03/14/1996WO1996007397A2 Delivery of solid drug compositions
03/14/1996DE4432557A1 Kapseln mit innenseitig hydrophober Beschichtung zur Aufnahme von matrixadsorbierten wäßrigen (radioaktiven) Lösungen und Verfahren zur Herstellung obiger Kapseln Capsules having a hydrophobic coating on the inside for receiving matrixadsorbierten aqueous (radioactive) solutions and methods for preparing the above capsules
03/14/1996DE4431832A1 Delayed release form of captopril in pellets in capsules
03/14/1996CA2199518A1 Heterocyclic derivative and medicine
03/14/1996CA2197714A1 Therapeutic treatment of clostridium difficile associated diseases
03/13/1996EP0700898A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
03/13/1996EP0700897A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
03/13/1996EP0700896A1 Photochemically cleavable metal chelating agents and compositions containing them
03/13/1996EP0700681A1 Nutritional transfusion for peripheral vein administration
03/13/1996EP0700680A1 Gepirone dosage form
03/13/1996EP0700679A1 Injectable liposomal compositions
03/13/1996EP0700678A1 Stable lipid emulsion
03/13/1996EP0700414A1 Polymer composition, absorbent material composition, their production and use
03/13/1996EP0700302A1 Method of treating diabetes mellitus
03/13/1996EP0700294A1 Intramuscular and subcutaneous injection solution for animals
03/13/1996EP0700290A1 Rectal compositions
03/13/1996EP0700289A1 Antidepressant dosage form
03/13/1996EP0700285A1 A drug delivery composition for alpha-adreno receptor blocking agents
03/13/1996EP0700284A1 Controlled release oxybutynin formulations
03/13/1996EP0700283A1 Liquid antacid compositions
03/13/1996EP0665746A4 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGF-g(a)PE 40?ab.
03/13/1996EP0664724B1 Process for extracting and rebuffering and/or concentrating dissolved macromolecules of a macromolecular mixture
03/13/1996EP0608306B1 Peroral drug delivery system
03/13/1996EP0605514B1 Controlled release pharmaceutical preparations
03/13/1996EP0591331B1 Method of preparing nanoparticles
03/13/1996EP0540613B1 Products and processes for the treatment of the alimentary canal
03/13/1996EP0472657B1 Method and composition for the treatment of thrombosis in a mammal
03/13/1996EP0438497B1 Vasopermeability-enhancing conjugates
03/13/1996CN2221972Y Minimized lipiodol capsule
03/13/1996CN1118576A Powdery pharmaceutical preparation and method of manufacturing same
03/13/1996CN1118575A Optical isomerization inhibitor
03/13/1996CN1118571A Bisacodyl dosage form
03/13/1996CN1118270A Anti-inflammatory agent for abdominal cavity
03/13/1996CN1118265A Capsule for eliminating pathogenic factor and alleviating pain
03/13/1996CN1118258A Preparation of brain-care pill
03/13/1996CN1118254A Pharmaceutical compositions having good dissolution properties
03/13/1996CN1118253A Metronizole effevescent tablet
03/13/1996CN1118252A Stabized solutions of platinum (II) antitumor agents
03/13/1996CA2157849A1 Injectable liposomal pharmaceutical preparations
03/12/1996US5498788 Inclusion complexes of clavulanic acid and of potassium salts thereof with hydrophobic β-cyclodextrin derivatives a process for the preparation thereof
03/12/1996US5498607 Anticholesterol agents
03/12/1996US5498598 Composition for nasal administration of desmopressin
03/12/1996US5498447 Spraying particles with thermally melted wax mixed with a heating gas; ejection; sustained release
03/12/1996US5498441 Dipping for coating, rotation and drying
03/12/1996US5498436 Coprocessed galactomannan-glucomannan
03/12/1996US5498426 Storage ph stable, calcium carbonate, potassium phosphate, potassium bicarbonate
03/12/1996US5498425 Phosphosoda buffered saline laxative
03/12/1996US5498424 Using clarithromycin to stimulate weight loss
03/12/1996US5498423 Method for correcting plasma melatonin levels and pharmaceutical formulation comprising melatonin
03/12/1996US5498422 Sustained release capsule
03/12/1996US5498421 Composition useful for in vivo delivery of biologics and methods employing same
03/12/1996US5498420 Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
03/12/1996US5498418 Nitroglycerine plaster and process for its production
03/12/1996US5498417 Transdermal delivery of appetite suppressant drug
03/12/1996US5498410 Method for the treatment of eosinophil-associated conditions with anionic polymers
03/12/1996US5498409 To remove endotoxins in medical solutions such as injections, tranfusions or saline, a polyethylenimine mixed with another polymer
03/12/1996US5498255 Osmotic device for protracted pulsatile delivery of agent
03/12/1996US5498254 Smooth muscle chemical pacemaker
03/09/1996CA2157837A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006638A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
03/07/1996WO1996006635A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996WO1996006631A1 Vancomycin hydrochloride suspensions for peroral use and for filling into soft gelatin capsules
03/07/1996WO1996006622A1 Hyaluronic acid and derivatives for modulation of cellular activity
03/07/1996WO1996006618A1 Cosolvent parenteral formulation of tirilazad
03/07/1996WO1996006617A1 Liposome preparation
03/07/1996WO1996006615A1 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides
03/07/1996WO1996006613A1 Topical ketoconazole emulsions
03/07/1996WO1996006608A1 Process for reducing the adverse taste and malodor associated with h2-antagonists
03/07/1996WO1996006605A1 Method of reducing body fat in animals by the administration of conjugated linoleic acid
03/07/1996WO1996006600A1 Transdermal therapeutic system with protection against hydrolysis
03/07/1996WO1996006599A1 Taste-making lipid-based liquid medicinal composition
03/07/1996WO1996006598A1 Aerosol drug formulations containing polyglycolyzed glycerides
03/07/1996WO1996006597A1 Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
03/07/1996WO1996006527A1 Sprayable film forming system releasing active substances for use on plants
03/07/1996WO1995019777A3 Use of diesters of muramyl peptides in oral form as immunostimulating agents
03/07/1996DE4431653A1 Manteltablette mit spitzem Kern Coated tablet with a pointed core
03/07/1996DE4431251A1 Skin cream, and base cream for cosmetics, eczema etc.
03/07/1996CA2198721A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996CA2198479A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
03/07/1996CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198080A1 Cell cycle regulated repressor and dna element
03/07/1996CA2196063A1 Cosolvent parenteral formulation of tirilazad
03/07/1996CA2195874A1 Aerosol drug formulations containing polyglycolyzed glycerides
03/06/1996EP0699689A1 Branched polysaccharide, microorganism producing it and compositions containing them
03/06/1996EP0699442A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties
03/06/1996EP0699439A2 Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
03/06/1996EP0699436A1 Controlled release formulation
03/06/1996EP0699433A2 Cosmetic or pharmaceutical composition containing chitosan derivatives
03/06/1996EP0699428A1 Cosmetic or dermatological composition comprising encapsulated extracts of cornflour
1 ... 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 ... 2991